Cardiac Devices and Testing

From the earliest reported cardiac surgeries in the late 19th century, exponential improvements in surgical techniques and operating times have opened the door for the development of novel cardiac devices. The design and development of cardiac devices in the 21st century is driven by the innovation and resources of an industry forecast to be worth $ 266 billion by 2012. This market growth is demonstrated by the many patent applications submitted each year to create novel devices or embellish existing products.

[1]  V. Gott Critical role of physiologist John A. Johnson in the origins of Minnesota's billion dollar pacemaker industry. , 2007, The Annals of thoracic surgery.

[2]  Paul A. Iaizzo Handbook of Cardiac Anatomy, Physiology, and Devices , 2005 .

[3]  P. Iaizzo Emerging Cardiac Devices and Technologies , 2009 .

[4]  V. Fuster,et al.  Thoughts on the role of the healing professions and the events of September 11, 2001. , 2002, Circulation.

[5]  W G BIGELOW,et al.  GENERAL HYPOTHERMIA FOR EXPERIMENTAL INTRACARDIAC SURGERY: THE USE OF ELECTROPHRENIC RESPIRATIONS, AN ARTIFICIAL PACEMAKER FOR CARDIAC STANDSTILL, AND RADIO-FREQUENCY REWARMING IN GENERAL HYPOTHERMIA , 1950, Annals of surgery.

[6]  P. Iaizzo,et al.  Isolated four-chamber working swine heart model. , 2000, The Annals of thoracic surgery.

[7]  Peter Johansen,et al.  Mechanical heart valve cavitation , 2004, Expert review of medical devices.

[8]  Andrew L. Rivard,et al.  Animal Models for Cardiac Research , 2005 .

[9]  R. McNamara,et al.  Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography , 2003, Annals of Internal Medicine.

[10]  H. Wiste,et al.  Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. , 2007, Journal of the American College of Cardiology.

[11]  F. Lewis,et al.  Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case. , 1953, Surgery.

[12]  D. Holmes,et al.  Bipolar Tined Polyurethane Ventricular Lead: A Four‐Year Experience , 1985, Pacing and clinical electrophysiology : PACE.

[13]  J. Copeland,et al.  Pediatric bridge to heart transplantation: application of the Berlin Heart, Medos and Thoratec ventricular assist devices. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  Karl T. Ulrich,et al.  Product Design and Development , 1995 .

[15]  P. Mykén,et al.  A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. , 2009, The Journal of thoracic and cardiovascular surgery.

[16]  S. Khuri,et al.  Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. , 1998, The Journal of thoracic and cardiovascular surgery.

[17]  P. Teirstein,et al.  Retrieval and analysis of particulate debris after saphenous vein graft intervention. , 1999, Journal of the American College of Cardiology.

[18]  K. Schulman,et al.  Early and long-term outcomes of heart failure in elderly persons, 2001-2005. , 2008, Archives of internal medicine.

[19]  R. Dewall Origin of the helical reservoir bubble oxygenator heart-lung machine , 2003, Perfusion.

[20]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[21]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[22]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006 .

[23]  J. Hanson Sixteen Failures in a Single Model of Bipolar Polyurethane‐insulated Ventricular Pacing Lead: A 44‐Month Experience , 1984, Pacing and clinical electrophysiology : PACE.

[24]  A. Cheung,et al.  Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  R. Phillips,et al.  Biomedical Applications of Polyurethanes: Implications of Failure Mechanisms , 1988, Journal of biomaterials applications.

[26]  P. Pastuszko,et al.  John H. Gibbon, Jr., the Inventor of the First Successful Heart–Lung Machine , 2004, Journal of cardiac surgery.

[27]  Frederick J Schoen,et al.  Calcification of tissue heart valve substitutes: progress toward understanding and prevention. , 2005, The Annals of thoracic surgery.

[28]  N. Piazza,et al.  Transcatheter mitral valve repair for functional mitral regurgitation: coronary sinus approach. , 2007, Journal of interventional cardiology.

[29]  Chai Jy,et al.  Medical device regulation in the United States and the European Union: a comparative study. , 2000 .

[30]  R. Gerisch,et al.  Temporary mechanical substitute for the left ventricle in man. , 1952, Journal of the American Medical Association.

[31]  N. Braunwald,et al.  Implications of late morphology of Braunwald-Cutter mitral heart valve prostheses. , 1984, The Journal of thoracic and cardiovascular surgery.

[32]  G. Crossley Cardiac pacing leads. , 2000, Cardiology clinics.

[33]  M. Leon,et al.  Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[34]  G. W. Hastings,et al.  Book reviewDefinitions in Biomaterials: Progress in Biomedical Engineering 4, Editor: D.F. Williams. Elsevier, Amsterdam, 1987, pp viii + 72, US $63.50 , 1989 .

[35]  K. Stokes,et al.  Ten‐Year Experience with Implanted Polyurethane Lead Insulation , 1986, Pacing and clinical electrophysiology : PACE.

[36]  H. Laks,et al.  Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[38]  E. C. Harrison,et al.  Lipids in Silicone Rubber Valve Prostheses After Human Implantation , 1971, Circulation.

[39]  W. Maisel Unanswered questions--drug-eluting stents and the risk of late thrombosis. , 2007, The New England journal of medicine.

[40]  Michael Simons,et al.  Medical Device Development: From Prototype to Regulatory Approval , 2004, Circulation.